Recovering from the ravages of the nine-year-long Iraq War which ended in 2011, the oil-and-gas rich Kurdistan Region in West Asia is now slowly getting on its feet in terms of development and progress for its 50-lakh (five million) .
714 Navi Mumbai-based Urologist-cum-regenerative medicine researcher Dr Pradeep V. Mahajan s stem-cell remedy kills Covid naturally. Image Source: IANS News
Mumbai, May 10
Concerned over the massive COVID-19 surge in the country, a Maharashtra researcher-cum-scientist has developed a unique stem-cell/platelet-based remedy to kill the Coronavirus naturally, with anti-inflammatory bodies and reduce the need for hospitalization of COVID patients by 65-75 per cent.
Navi Mumbai-based Urologist-cum-regenerative medicine researcher Dr Pradeep V. Mahajan, 61, said that the stem-cell/lyophilised platelet remedy is a proven protocol for COVID and post-COVID patients on OPD basis, without requiring hospitalization for targeting the primary lung disease.
Dr Mahajan Chairman of StemRx Biosciences Solutions Pvt Ltd said that the lungs are the prime target of Covid, causing maximum morbidity, highest stay in ICU/ventilators and deaths, and post-treatment, the patient requires oxygen
URL copied
Maharashtra scientist s stem-cell remedy kills Covid naturally
Concerned over the massive COVID-19 surge in the country, a Maharashtra researcher-cum-scientist has developed a unique stem-cell/platelet-based remedy to kill the Coronavirus naturally, with anti-inflammatory bodies and reduce the need for hospitalization of COVID patients by 65-75 per cent.
Navi Mumbai-based Urologist-cum-regenerative medicine researcher Dr Pradeep V. Mahajan, 61, said that the stem-cell/lyophilised platelet remedy is a proven protocol for COVID and post-COVID patients on OPD basis, without requiring hospitalization for targeting the primary lung disease.
Dr Mahajan - Chairman of StemRx Biosciences Solutions Pvt Ltd - said that the lungs are the prime target of Covid, causing maximum morbidity, highest stay in ICU/ventilators and deaths, and post-treatment, the patient requires oxygen for several months as lungs develop fibrosis.